FIG 3.
Liver lesion penetration of MGX at 24 h after repeated dosing of FMGX for 2 or 3 days. The significant lesion/nonlesion MGX concentration ratio difference is noted as ** (P < 0.01).
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.